Want to see AIM full AI Analyst Report?
Total Valuation
AIM ImmunoTech has a market cap or net worth of $7.37M. The enterprise value is -$1.18.
Market Cap$7.37M
Enterprise Value-$1.18
Share Statistics
AIM ImmunoTech has 35,507,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding35,507,980
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AIM ImmunoTech’s return on equity (ROE) is 1.43 and return on invested capital (ROIC) is -313.55%.
Return on Equity (ROE)1.43
Return on Assets (ROA)-2.41
Return on Invested Capital (ROIC)-313.55%
Return on Capital Employed (ROCE)23.81
Revenue Per Employee4.63K
Profits Per Employee-734.63K
Employee Count19
Asset Turnover0.02
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of AIM ImmunoTech is ―. AIM ImmunoTech’s PEG ratio is 0.00565.
PE Ratio―
PS Ratio20.78
PB Ratio-0.19
Price to Fair Value-0.19
Price to FCF-0.16
Price to Operating Cash Flow-0.51
PEG Ratio0.00565
Income Statement
In the last 12 months, AIM ImmunoTech had revenue of 88.00K and earned -13.96M in profits. Earnings per share was -8.62.
Revenue88.00K
Gross Profit-250.00K
Operating Income-10.53M
Pretax Income-13.96M
Net Income-13.96M
EBITDA-12.94M
Earnings Per Share (EPS)-8.62
Cash Flow
In the last 12 months, operating cash flow was -7.07M and capital expenditures -95.00K, giving a free cash flow of -7.16M billion.
Operating Cash Flow-7.07M
Free Cash Flow-7.16M
Free Cash Flow per Share-0.20
Dividends & Yields
AIM ImmunoTech pays an annual dividend of $0.272, resulting in a dividend yield of ―
Dividend Per Share$0.272
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.96
52-Week Price Change-92.65%
50-Day Moving Average0.24
200-Day Moving Average0.66
Relative Strength Index (RSI)36.85
Average Volume (3m)8.52M
Important Dates
AIM ImmunoTech upcoming earnings date is Aug 17, 2027, TBA (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateAug 17, 2027
Ex-Dividend Date―
Financial Position
AIM ImmunoTech as a current ratio of 0.53, with Debt / Equity ratio of 50.63%
Current Ratio0.53
Quick Ratio0.53
Debt to Market Cap2.58
Net Debt to EBITDA-0.31
Interest Coverage Ratio-12.96
Taxes
In the past 12 months, AIM ImmunoTech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
AIM ImmunoTech EV to EBITDA ratio is -0.45, with an EV/FCF ratio of -0.51.
EV to Sales65.84
EV to EBITDA-0.45
EV to Free Cash Flow-0.51
EV to Operating Cash Flow-0.53
Balance Sheet
AIM ImmunoTech has $9.96M in cash and marketable securities with $3.92M in debt, giving a net cash position of $6.04M billion.
Cash & Marketable Securities$9.96M
Total Debt$3.92M
Net Cash$6.04M
Net Cash Per Share$0.17
Tangible Book Value Per Share-$7.07
Margins
Gross margin is -125.26%, with operating margin of -11961.36%, and net profit margin of -15861.36%.
Gross Margin-125.26%
Operating Margin-11961.36%
Pretax Margin-15861.36%
Net Profit Margin-15861.36%
EBITDA Margin-14700.00%
EBIT Margin-14938.64%
Analyst Forecast
The average price target for AIM ImmunoTech is $4.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.25
Price Target Upside1600.00% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-21.49%
EPS Growth Forecast84.62%